Zhengyan Kan

Title: Zhengyan Kan: Innovator in Acetyl-CoA Carboxylase Research

Introduction

Zhengyan Kan is a notable inventor based in Bellevue, WA, who has made significant contributions to the field of biochemistry. His work primarily focuses on the innovative aspects of acetyl-CoA carboxylase 2 (ACC2), a crucial enzyme involved in fatty acid metabolism.

Latest Patents

Zhengyan Kan holds a patent for an alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2). This invention features nucleic acids and polypeptides encoding novel splice variant isoforms of ACC2. The polynucleotide sequence of ACC2sv1 is provided by SEQ ID NO 3, while the amino acid sequence of ACC2sv1 is provided by SEQ ID NO 4. The patent also outlines methods for using ACC2sv1 polynucleotides and proteins to screen for compounds that bind to ACC2sv1.

Career Highlights

Zhengyan Kan is associated with Rosetta Inpharmatics, Inc., where he applies his expertise in biochemistry and molecular biology. His innovative research has the potential to impact various applications in drug discovery and metabolic disease treatment.

Collaborations

Zhengyan Kan has collaborated with notable colleagues, including Philip W Garrett-Engele and Christopher D Armour. These collaborations have further enriched his research and contributed to advancements in the field.

Conclusion

Zhengyan Kan's work in the development of novel splice variants of acetyl-CoA carboxylase 2 showcases his innovative spirit and dedication to advancing biochemistry. His contributions are poised to influence future research and applications in metabolic health.